Bridging Supply Chain Gaps in Clinical Trial Logistics for mRNA Vaccines

Article Summary: The rapid spread of the original virus strain and its subsequent variants across the globe highlighted the importance of vaccine technologies which were capable of swift deployment for human trials with efficacy and safety remaining top priorities.   Challenges in the mRNA vaccine supply chain As mRNA vaccines take centre stage, the challenges […]

Major AUD$280 million investment to deliver mRNA 2.0

Excerpt Sanofi, one of the world’s largest vaccine innovators, has partnered with the Queensland Government to inject AUD$280 million into next generation mRNA vaccine research in Queensland. Article Summary Sanofi and Queensland Premier Annastacia Palaszczuk today announced the creation of the Translational Science Hub, which will connect top researchers in Queensland with those at the […]

Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia

Excerpt ChulaCov19 mRNA vaccine was found safe and immunogenic for primary immunization in clinical trials in Thailand. The Australian trial will evaluate the safety and immunogenicity of a booster dose of ChulaCov19 BNA159 mRNA vaccine in healthy volunteers. The collaborators of the trial are Chulalongkorn University, BioNet and Technovalia. Article Summary The phase 2 trial […]

Vaxxas raises US$23 million (A$34 million) to develop needle-free vaccines, including a COVID-19 vaccine candidate of the next generation

Excerpt Vaxxas will advance numerous vaccination programmes in the clinic and build up manufacturing resources for commercial production. More than US$67 million (A$100 million) in non-dilutive financial support has been provided and pledged via contracts with US and Australian government agencies, industry partners, and international health organisations. Equity investment is being used to leverage this […]

First foreign COVID vaccines head to China from Germany

Excerpt   The vaccines are on the way from China Berlin encourages increased usage, German citizens are encouraged to get vaccinated Batches of vaccines to release after Scholz visit to China There is increased spike in infections hence this batch was introduced   Article Summary Berlin sent its first batch of BioNTech (22UAy.DE) COVID-19 vaccines […]

Abu Dhabi Airports joins Pharma.Aero

Article Summary: Abu Dhabi Airports has joined Pharma.Aero as a strategic member representing the Middle East. Pharma.Aero is the global membership network for life science and medtech manufacturers, certified cargo communities and airport operators. The collaboration with Pharma.Aero builds on Abu Dhabi’s growth as a global healthcare and life sciences hub, and the success of […]

Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

Excerpt TAK-003 is advised for use in the EU and in dengue-endemic nations taking part in the EU-M4all procedure to prevent dengue disease in people four years of age and older caused by any dengue virus serotype. Marketing Authorization is anticipated in Europe in the coming months, followed by Regulatory Decisions in Latin America and […]

IndoVac Productions Bio Farma to Strengthen Indonesia’s Health Infrastructure

Excerpt Bio Farma as a Pharmaceutical BUMN Holding, supported the government’s steps and efforts in strengthening health infrastructure, one of which is through the independence of the Covid-19 vaccine. This concrete step is realized by Bio Farma through its success in producing the IndoVac Vaccine which was officially launched by President Joko Widodo.  Article Summary […]

Experimental breast cancer vaccine proves safe in phase 1 clinical trials

Excerpt Recent studies on an experimental vaccine for breast cancer under the direction of Dr. Mary (Nora) L. Disis at the University of Washington Medicine Cancer Vaccine Institute have demonstrated that this vaccine induces a potent immune response to the important tumour protein ERBB2, formerly known as HER2. Article Summary In a study published in […]

CanSino Biologics Celebrates the Rollout of the Inhaled Vaccine, Convidecia Air™, in Shanghai

Excerpt Cansino Biologics announced that the Joint Prevention and Control Mechanism of the State Council of China had approved its Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) for Inhalation (trade name: Convidecia AirTM) for inclusion in Shanghai’s booster vaccination programme. This marks the beginning of the rollout of the world’s first inhaled COVID-19 vaccine, Convidecia […]

RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates

Excerpt RVAC Medicines Pte. Ltd., an mRNA technology platform company launched by CBC Group in 2021 announced first-in-human study evaluating the business’s mRNA-based COVID-19 vaccine candidate, RVM-V001 Article Summary RVAC Medicines Pte. Ltd., an mRNA technology platform company launched by CBC Group in 2021 announced first-in-human study evaluating the business’s mRNA-based COVID-19 vaccine candidate, RVM-V001 […]

Indonesia approves first home-grown COVID vaccine for emergency use 

Excerpt Indonesia has approved its first domestically-produced COVID-19 vaccine for emergency use for people over 18 Article Summary Indonesia has approved its first domestically-produced COVID-19 vaccine for emergency use for people over 18 The Indovac vaccine has been developed by Indonesia’s state-owned pharmaceutical company Bio Farma and the Texas Children’s Hospital Center for Vaccine Development […]

bag